Bone Marrow TransplantationHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningStem CellsBone MarrowBone Marrow CellsLiver TransplantationHematopoietic Stem CellsHematologic NeoplasmsGraft SurvivalTransplantation ChimeraCord Blood Stem Cell TransplantationWhole-Body IrradiationHematopoietic Stem Cell MobilizationTissue DonorsBusulfanCombined Modality TherapyTreatment OutcomeKidney TransplantationCyclophosphamideMelphalanLeukemiaGranulocyte Colony-Stimulating FactorHistocompatibility TestingRecurrenceHistocompatibilityAntigens, CD34Anemia, AplasticRemission InductionTransplantation, IsogeneicImmunosuppressive AgentsMultiple MyelomaLeukapheresisHematopoiesisAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsHeart TransplantationMesenchymal Stem Cell TransplantationTime FactorsRetrospective StudiesLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteEmbryonic Stem CellsTransplantation ImmunologyLung TransplantationBone Marrow PurgingBone and BonesCell TransplantationSurvival AnalysisGraft RejectionCell DifferentiationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival RateDisease-Free SurvivalAdult Stem CellsGraft vs Leukemia EffectBlood Component RemovalEtoposideHematologic DiseasesBone Marrow DiseasesImmunosuppressionPrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic SyndromesInfectionOrgan TransplantationHLA AntigensLymphocyte DepletionHepatic Veno-Occlusive DiseaseMice, Inbred C57BLFollow-Up StudiesCytarabineSalvage TherapyAntineoplastic Agents, AlkylatingCyclosporineCytomegalovirus InfectionsAcute DiseaseVidarabineHodgkin DiseaseCarmustineThiotepaPluripotent Stem CellsT-LymphocytesLymphomaLymphocyte TransfusionFatal OutcomeGraft vs Tumor EffectBlood CellsStem Cell NicheIslets of Langerhans TransplantationTransplantationMesenchymal Stromal CellsColony-Forming Units AssayLeukemia, MyeloidCells, CulturedPancreas Transplantation